SCHEMBL19625473

SCHEMBL19625473

CCN1CCN(c2cc(F)c(-c3csc(C(C)(C)C)n3)cc2F)CC1

nearest known ligand 0.42

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 5/20 0.42
MAPT P10636 11/20 0.39
LMNA P02545 3/20 0.39
TP53 P04637 2/20 0.36
GAA P10253 3/20 0.36
KMT2A Q03164 1/20 0.36
THRB P10828 1/20 0.35
HRH1 P35367 1/20 0.34
RAD52 P43351 1/20 0.34
GFER P55789 1/20 0.34
OPRL1 P41146 1/20 0.33
KDM4E B2RXH2 2/20 0.33
HPGD P15428 1/20 0.33
HSD17B10 Q99714 1/20 0.33
RAB9A P51151 2/20 0.33
SMN1; SMN2 Q16637 2/20 0.33
NPC1 O15118 1/20 0.33
CYP1A2 P05177 1/20 0.33
POLB P06746 1/20 0.33
CYP2D6 P10635 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL19626770 0.87 ALDH1A1 (0.47) ALDH1A1MAPTLMNATP53GAA
SCHEMBL19625470 0.87 TSHR (0.37) ALDH1A1MAPTLMNAKMT2AKDM4E
SCHEMBL19625481 0.84 AR (0.44) ALDH1A1LMNAHPGDRAB9ANPC1
SCHEMBL17626150 0.77 ALDH1A1 (0.43) ALDH1A1MAPTLMNATP53GAA
SCHEMBL19625439 0.76 MAPT (0.48) ALDH1A1MAPTTP53GAAKMT2A
SCHEMBL19626610 0.75 MPL (0.41) MAPTGAARAD52GFER
SCHEMBL19626783 0.73 TSHR (0.40) ALDH1A1MAPTLMNAGAAKMT2A
SCHEMBL19625390 0.71 LATS1 (0.35) ALDH1A1MAPTKMT2ATHRBKDM4E
SCHEMBL19626775 0.70 AR (0.46) ALDH1A1MAPTGAAHPGDHSD17B10
SCHEMBL19625461 0.69 ALDH1A1 (0.43) ALDH1A1GAAKDM4EHPGDRAB9A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-10472360-B2 Purine diones as Wnt pathway modulators AGENCY FOR SCIENCE, TECHNOLOGY AND RESEARCH (SG) 2019-11-12 US disclosed
US-20170334912-A1 Purine Diones As Wnt Pathway Modulators AGENCY FOR SCIENCE, TECHNOLOGY AND RESEARCH (SG) 2017-11-23 US disclosed
US-20170334912-A1 Purine Diones As Wnt Pathway Modulators AGENCY FOR SCIENCE, TECHNOLOGY AND RESEARCH (SG) 2017-11-23 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20170334912-A1 Purine Diones As Wnt Pathway Modulators WNT1, WNT3A, CTNNB1 ALDH1A1 1166/4885MAPT 4783/4885LMNA 2300/4885
US-10472360-B2 Purine diones as Wnt pathway modulators WNT1, WNT3A, CTNNB1 ALDH1A1 1166/4885MAPT 4783/4885LMNA 2300/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.